AstraZeneca prepares to sell five-, seven-, 10-year notes

Chicago, Feb. 28 – AstraZeneca Finance LLC is offering three tranches of fixed-rate notes, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will be guaranteed by AstraZeneca plc.

All three notes will be optionally redeemable, first with make-whole premiums and then at par.

BofA Securities, Inc., HSBC Securities (USA) Inc., Mizuho Securities USA LLC and Santander US Capital Markets LLC are listed as joint bookrunners.

Bank of New York Mellon will serve as the trustee.

Freshfields Bruckhaus Deringer US LLP is advising the issuer for legal matters. Counsel to the underwriters is provided by Simpson Thacher & Bartlett LLP.

Proceeds will be used for general corporate purposes, including refinancing existing debt, which may include outstanding debt under bank facilities provided by the underwriters.

Listing will be on the Nasdaq Stock Market.

The pharmaceutical company is based in Cambridge, U.K.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.